“To Patent or Not to Patent? The Case of Novartis’ Cancer Drug Glivec in India”
Globalization and Health - United Kingdom
doi 10.1186/1744-8603-10-3
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Springer Science and Business Media LLC